Evidence map›Paper›PMID 29803655›Full record

ArticleBehavioural brain research2018

Insulin dependent and independent normalization of blood glucose levels reduces the enhanced rewarding effects of nicotine in a rodent model of diabetes.

Javier Íbias, Laura E O'Dell, Arbi Nazarian

Open access · greenAbstract read
In one paragraph

Article in Behavioural brain research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Insulin modulates the strong reinforcing effects of nicotine and changes in insulin biomarkers in a rodent model of diabetes.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Javier ÍbiasDepartment of Pharmaceutical Sciences, Western University of Health Sciences, Pomona, CA, USA.
Laura E O'DellDepartment of Psychology, University of Texas at El Paso, El Paso, TX, USA.
Arbi NazarianDepartment of Pharmaceutical Sciences, Western University of Health Sciences, Pomona, CA, USA. Electronic address: anazarian@westernu.edu.
Western University of Health Sciences · USThe University of Texas at El Paso · US

Funding

Insulin mechanisms of diabetes-evoked enhancement of nicotine rewardR15DA040130 · NIDA · WESTERN UNIVERSITY OF HEALTH SCIENCES · PI NAZARIAN, ARBI · 2015 to 2016
$546k
NIDA NIH HHS R15 DA040130
6 · The paper itself

Abstract

The rewarding effects of nicotine have been previously shown to be enhanced in rodent models of diabetes. It is presently unclear whether the enhanced nicotine reward observed in the diabetes models are mediated via an insulin or glucose mechanism. This study examined whether the enhanced rewarding effects of nicotine observed in streptozotocin (STZ)-treated rats are insulin-mediated. Male and female rats were treated with STZ and the rewarding effects of nicotine (0.2 mg/kg) were measured using the conditioned place preference (CPP) procedure. Some STZ-treated animals received insulin supplementation via subcutaneous pellets immediately after STZ administration, while other rats received daily injections of dapagliflozin (10 mg/kg), a sodium-glucose cotransporter-2 inhibitor. Both male and female STZ-treated rats displayed hyperglycemia, and their blood glucose levels (BGLs) were normalized to control levels following insulin supplementation or dapagliflozin administration. STZ-treated male rats displayed higher nicotine CPP relative to vehicle-treated controls. This effect was abolished in rats that received insulin supplementation or dapagliflozin administration. STZ-treated female rats displayed reduced levels of nicotine CPP as compared to male rats, regardless of treatment condition. These results suggest that glucose plays a major role in modulating the rewarding effects of nicotine in male rats treated with STZ.

Indexed as

RewardAnimalsBenzhydryl CompoundsBlood GlucoseConditioning, PsychologicalDiabetes Mellitus, ExperimentalFemaleGlucosidesHyperglycemiaHypoglycemic AgentsInsulinMaleNicotineNicotinic AgonistsBenzhydryl CompoundsBlood GlucosedapagliflozinGlucosidesHypoglycemic AgentsInsulinNicotineNicotinic AgonistsDapagliflozinDiabetesHyperglycemiaInsulinPlace preferenceStreptozotocin

Identifiers

PMID29803655
PMCPMC6026546
OpenAlexW2803678423

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.